Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to determine that adjuvant systemic chemotherapy is superior to adjuvant transcatheter arterial chemoembolization(TACE) in prolonging recurrence free survival(RFS) in patients after radical resection of hepatocellular carcinoma.
Epistemonikos ID: 38ca5aec668f5a4e2a9ca48fa9653f77860e8b98
First added on: May 12, 2024